IMPORTANCE OF INDIVIDUAL APPROACH TO THE IMMUNOPROPHYLAXIS OF RECURRENT UROGENITAL INFECTION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Prevention of recurrence of urinary tract infections by Uro-Vaxom is recommended by domestic and international guidelines; up to date, however, there is no reasonable standard regimen for the use of drug, and long-term results of immunoprophylaxis were not evaluated. The study included 48 patients who received a first course of Uro-Vaxom 5 years ago (2007-2008), including 19 men with chronic bacterial prostatitis/urethroprostatitis and 29 women with recurrent cystitis. Over 5 years, 125 recurrences of urogenital infection were observed; Uro-Vaxom along with antibiotics or uroseptics in combination with phytopreparations was used in 88 (70,4%) cases, and in the remaining 37 (29,6%) cases monotherapy with Uro-Vaxom was used for the relief of inflammatory processes. During the follow-up period, 254 1-month courses of treatment with Uro-Vaxom were conducted; 125 (49,2%) courses were assigned for the treatment of recurrent urogenital infection, and 129 (50,8 %) - for the prevention without exacerbation of underlying disease. The main indications for use were intercurrent infection, mainly respiratory - 86 (66,7%) cases, stress - 14 (10,8%); in 29 (22,5%) cases, the patients have received Uro-Vaxom focusing on their feelings without a doctor's prescription.

Full Text

Restricted Access

About the authors

E. V Kulchavenya

Email: urotub@yandex.ru

A. A Breusov

References

  1. Naber K.G., Cho Y.H., Matsumoto T., Schaeffer A.S. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int. J. Antimicrob. Agents 2009; 33(2): 111-119.
  2. Krieger J.N. Urinary tract infections: what’s new? J. Urol. 2002; 168: 2351-2358.
  3. Nicolle L.E. Asymptomatic bacteriuria in the elderly. Infect. Dis. Clin. North Am. 1997; 11: 647-662.
  4. Kun Suk Kim, Ji-Yoon Kim, In Gab Jeong et al. A prospective Multi-center Trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis. J. Korean Med. Sci. 2010; 25: 435-439.
  5. Huber M., Krauter K., Winkelmann G. et al. Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int. J. Immunopharmacology. 2000; 22: 1103-1111.
  6. Bauer H.W., Rahls W., Lauener P.A., Plessmann G.S. Prevention of recurrent urinary tract infections with immuno-active E.Coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int. J. Antimicrob. Agents 2002; 19(6): 451-456.
  7. Schulman C.C., Corbusier A., Michiels H. et al. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebocontrolled multicenter study. J Urol 1993; 150: 917-921.
  8. Magasi P., Panovics J., Illes A. et al. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomizes multicenter double-blind trial. Eur. Urol. 1994; 26: 137-140.
  9. Hachen H.J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. J. Urol. 1990; 143: 759-763.
  10. Tammen H. and the German urinary tract infection study group. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. Br. J Urol. 1990; 65: 6-9.
  11. Schneider H.-J. New therapeutic approach for recurrent urinary tract infections. Marked reduction in recurrence rate in women with uncomplicated cystitis - few side effects, high compliance. Der Allgemeinarzt. 1990; 12: 626-633.
  12. Popa G., Lauber K.-D., Rothe H. et al. Rezidivierende Harnwegsinfektionen in der Postmenopause. Wirksamkeit einer oralen Immuntherapie mit E. Coli-fraktionen. Munch med Wschr 1996; 138: 713-716.
  13. Schmidhammer S., Ramoner R., Holtl L. et al. An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. Urology. 2002 (3); 606: 521-526.
  14. Thilagarajah R., Witherow R.O., Walker M.M. Quantitative hystopathology can aid diagnosis in painful bladder syndrome. J. Clin. Pathol. 1998; 51: 211-214.
  15. Bessler W.G., vor dem Esche U., Zgaga-Griesz A. et al. Immunostimulatory properties of the bacterial extract OM-89 in vitro and in vivo. Arzneimittelforschung. 2010; 60(6): 324—329.
  16. Bauer H.W., Alloussi S., Egger G. et al. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur. Urol. 2005; 47(4): 542-548.
  17. Кульчавеня Е.В., Бреусов А.А. Эффективность уро-ваксома при рецидивирующих инфекционно-воспалительных заболеваниях мочеполовой системы. Урология. 2011; 4: 7-11.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies